<VariationArchive VariationID="1702938" VariationName="NM_001166345.3(MDFIC):c.391dup (p.Met131fs)" VariationType="Duplication" Accession="VCV001702938" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-19" DateCreated="2022-08-29" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1695331" VariationID="1702938">
      <GeneList>
        <Gene Symbol="MDFIC" FullName="MyoD family inhibitor domain containing" GeneID="29969" HGNC_ID="HGNC:28870" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.1-31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="114922094" stop="115019917" display_start="114922094" display_stop="115019917" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="114562208" stop="114659969" display_start="114562208" display_stop="114659969" Strand="+" />
          </Location>
          <OMIM>614511</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001166345.3(MDFIC):c.391dup (p.Met131fs)</Name>
      <CanonicalSPDI>NC_000007.14:114979673:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="114979673" stop="114979674" display_start="114979673" display_stop="114979674" variantLength="1" positionVCF="114979673" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="114619728" stop="114619729" display_start="114619728" display_stop="114619729" variantLength="1" positionVCF="114619728" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>M131fs</ProteinChange>
      <ProteinChange>M240fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.114619734dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.114619734dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.114979679dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.114979679dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029463.1" sequenceAccession="NG_029463" sequenceVersion="1" change="g.62526dup">
            <Expression>NG_029463.1:g.62526dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166345.3" sequenceAccession="NM_001166345" sequenceVersion="3" change="c.391dup" MANESelect="true">
            <Expression>NM_001166345.3:c.391dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159817.1" sequenceAccession="NP_001159817" sequenceVersion="1" change="p.Met131fs">
            <Expression>NP_001159817.1:p.Met131fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199072.5" sequenceAccession="NM_199072" sequenceVersion="5" change="c.718dup">
            <Expression>NM_199072.5:c.718dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_951038.1" sequenceAccession="NP_951038" sequenceVersion="1" change="p.Met240fs">
            <Expression>NP_951038.1:p.Met240fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199072.4" sequenceAccession="NM_199072" sequenceVersion="4" change="c.718dupA">
            <Expression>NM_199072.4:c.718dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="614511.0001" DB="OMIM" />
        <XRef Type="rs" ID="562142736" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001166345.3(MDFIC):c.391dup (p.Met131fs) AND Lymphatic malformation 12" Accession="RCV002279857" Version="2">
        <ClassifiedConditionList TraitSetID="79383">
          <ClassifiedCondition DB="MedGen" ID="C5774203">Lymphatic malformation 12</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001166345.3(MDFIC):c.391dup (p.Met131fs) AND MDFIC-related disorder" Accession="RCV003418436" Version="4">
        <ClassifiedConditionList TraitSetID="91925">
          <ClassifiedCondition>MDFIC-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-19" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-08-29" MostRecentSubmission="2023-11-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">35235341</ID>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="91925" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70894" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">MDFIC-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MDFIC-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="79383" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CENTRAL CONDUCTING LYMPHATIC ANOMALY</ElementValue>
                <XRef Type="MIM" ID="620014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lymphatic malformation 12</ElementValue>
                <XRef ID="MONDO:0031043" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LMPHM12</ElementValue>
                <XRef Type="MIM" ID="620014" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CCLA</ElementValue>
                <XRef Type="MIM" ID="620014" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774203" DB="MedGen" />
              <XRef ID="MONDO:0031043" DB="MONDO" />
              <XRef Type="MIM" ID="620014" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5021641" SubmissionDate="2022-08-23" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="614511.0001_LYMPHATIC MALFORMATION 12" title="MDFIC, 1-BP DUP, 391A_LYMPHATIC MALFORMATION 12" />
        <ClinVarAccession Accession="SCV002567898" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-23">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 20-year-old Iranian woman (family LE-410) and 4-month-old European boy (CHOP-1) with lymphedema and recurrent pleural and pericardial effusions due to lymphatic malformation (LMPHM12; 620014), as well as an affected boy of Middle Eastern descent (family LE-590) who died at age 7 years of septic shock, Byrne et al. (2022) identified homozygosity for a 1-bp duplication in exon 4 of the MDFIC gene (c.391dupA, NM_001166345.1), causing a frameshift predicted to result in a premature termination codon (Met131AsnfsTer3, M131NfsX3). In 2 Chinese brothers (LE-452) with lymphatic malformation, 1 who died at birth and 1 who was 6 years old, the authors identified compound heterozygosity for the same duplication and a c.732T-G transversion in exon 5 of MDFIC, resulting in a phe244-to-leu (F244L; 614511.0002) substitution. Both variants segregated with disease in the respective families, and were present at low minor allele frequency in the gnomAD database. Experiments in HEK293 cells demonstrated selective coimmunoprecipitation of wildtype MDFIC with GATA2 (137295), suggesting that physical interaction between MDFIC and GATA2 might contribute to selective localization of MDFIC in lymphatic vessel and cardiac valves where GATA2 levels are high. No interaction was detected between the analogous mouse M131Nfs mutant and GATA2, although a F245L mouse mutant, analogous to the human F244L mutation, retained the ability to interact with GATA2. Analysis of adhesion to and migration of human lymphatic endothelial cells (hLECs) on a variety of extracellular matrices suggested that reduction in MDFIC results in increased activation of integrin beta-1 (ITGB1; 135630) and increased attachment of hLECs to the basal matrix, resulting in less ability to undergo collective cell migration, an important event underpinning leaflet formation during lymphatic vessel valve development.</Attribute>
              <Citation>
                <ID Source="PubMed">35235341</ID>
              </Citation>
              <XRef DB="OMIM" ID="620014" Type="MIM" />
              <XRef DB="OMIM" ID="137295" Type="MIM" />
              <XRef DB="OMIM" ID="135630" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MDFIC" />
          </GeneList>
          <Name>MDFIC, 1-BP DUP, 391A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 391A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614511.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LYMPHATIC MALFORMATION 12</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569923" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_199072.5:c.718dup|Lymphatic malformation 12" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046198" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant results in a c.391dup (p.Met131) change in an alternate MDFIC transcript NM_001166345.1. This frameshifting variant in exon 4 of 5 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a homozygous and compound heterozygous change in patients with Central conducting lymphatic anomaly (PMID: 35235341). Functional studies confirm this variant results in a truncated protein (PMID: 35235341). The c.718dup (p.Met240AsnfsTer3) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.01770% (50/282438) and thus is presumed to be rare. Based on the available evidence, the c.718dup (p.Met240AsnfsTer3) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MDFIC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_199072.5:c.718dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Lymphatic malformation 12</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7700421" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="929768|MDFIC-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004116381" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The MDFIC c.718dupA variant is predicted to result in a frameshift and premature protein termination (p.Met240Asnfs*3). Using an alternate transcript (NM_001166345), this variant is also referred to as c.391dupA (p.Met131Asnfs*3) in the literature. This variant has been reported in the homozygous and compound heterozygous states, in individuals with central conducting lymphatic anomaly with lymphedema (Byrne et al. 2022. PubMed ID: 35235341). This variant is reported in 0.026% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-114619728-C-CA). Frameshift variants in MDFIC are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MDFIC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_199072.4:c.718dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MDFIC-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7569923" TraitType="Disease" MappingType="Name" MappingValue="Lymphatic malformation 12" MappingRef="Preferred">
        <MedGen CUI="C5774203" Name="Lymphatic malformation 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7700421" TraitType="Disease" MappingType="Name" MappingValue="MDFIC-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="MDFIC-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5021641" TraitType="Disease" MappingType="Name" MappingValue="LYMPHATIC MALFORMATION 12" MappingRef="Preferred">
        <MedGen CUI="C5774203" Name="Lymphatic malformation 12" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

